CVS Health reported first quarter earnings per share of $2.57 and revenue of $100.4 billion, both exceeding analyst expectations. The company credited improved performance in its Aetna health insurance business and growth in its Health Care Benefits and Pharmacy & Consumer Wellness segments. As a result, CVS raised its full-year 2026 adjusted EPS guidance to $7.30-$7.50 and increased its cash flow forecast to at least $9.5 billion. Despite the positive outlook, CVS remains cautious due to ongoing cost pressures and potential economic challenges.
Aetna's latest survey shows U.S. healthcare providers' trust in payers increased to a score of 6.1 from 5.4, reflecting improved perceptions of payer reliability and communication. Providers highlight technology's role in reducing administrative task...
CVS Caremark announced a global settlement with the Federal Trade Commission (FTC) resolving all litigation related to rebate practices, pharmacy network contracting, and vertical integration. The agreement ends ongoing investigations and allows CVS ...
